The global artificial intelligence in diagnostics market size is expected to reach USD 3.0 billion by 2027, expanding at a CAGR of 32.3%, according to a new report by Grand View Research, Inc. Increase in the number of healthcare Artificial Intelligence (AI) diagnostic startups coupled with huge investments by venture capitalist firms to develop innovative technologies that allow fast and effective diagnostic procedures due to continuous increase in number of patients suffering from chronic diseases supports the growth of the market. Around 33.3% of all healthcare AI SaaS companies are engaged in developing diagnostics, making it largest focus area for startups in the market.
Request a sample Copy of the Global Artificial Intelligence In Diagnostics Market Research Report @ https://www.grandviewresearch.com/industry-analysis/artificial-intelligence-diagnostics-market/request/rs1
Growing investments and funding for AI in healthcare is also one of the key factors driving the market. For instance, in 2016, the U.S.-based startup, PathAI, secured USD 75.2 million investment for developing machine learning technology that assists pathologists in making more precise diagnosis. Rising investments in AI diagnosis-based startups is one of the key indicators that depicts upcoming opportunities.
Moreover, increasing adoption of AI technology by hospitals and research centers for clinical diagnosis purpose is another factor propelling market growth. For instance, in July 2018, two national research institutes in Japan succeeded in implementing AI technology for detecting early stage stomach cancer with high precision rate of 95.0% for healthy tissues and 80.0% for cancer tissues. According to National Cancer Centre and Riken, AI technology took 0.004 seconds to identify whether obtained endoscopic image contains normal stomach tissue or early stage cancer tissue. Growing awareness regarding the technology is expected to boost the usage of AI in medical procedures.
Key suggestions from the report:
- Software emerged as leading component segment in 2019 with a revenue share of 38.6% in the market
- The neurology segment accounted for the largest revenue share in 2019, whereas radiology segment is projected to expand at fastest CAGR during the forecast period
- North America accounted for the largest share due to growing adoption of healthcare IT solutions in medical diagnosis and presence of well-established healthcare sector in the region.
Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/450613/ibb
Grand View Research has segmented the artificial intelligence in diagnostics market on the basis of component, diagnosis type, and region:
Artificial Intelligence (AI) In Diagnostics Component Outlook (Revenue, USD Million, 2015 – 2027)
- Software
- Hardware
- Services
Artificial Intelligence (AI) In Diagnostics Diagnosis Type Outlook (Revenue, USD Million, 2015 – 2027)
- Cardiology
- Oncology
- Pathology
- Radiology
- Chest and Lung
- Neurology
- Others
Artificial Intelligence (AI) In Diagnostics Regional Outlook (Revenue, USD Million, 2015 – 2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Asia Pacific
- Japan
- China
- India
- Australia
- Singapore
- South Korea
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
List of Key Players in the Artificial Intelligence In Diagnostics Market
- Aidoc
- AliveCor
- GE Healthcare
- Imagen Technologies
- Vuno Inc.
- IDx Technologies Inc.
- Siemens Healthcare GmbH
- Neural Analytics
- Riverain Technologies,
- Zebra Medical Vision
Find more research reports on Healthcare IT Industry, by Grand View Research:
Infection Surveillance Solutions Market – The global infection surveillance solutions market size was valued at USD 303.7 million in 2017.
Blockchain Technology in Healthcare Market – The global blockchain in technology healthcare market size was estimated at USD 231.0 million in 2018 and is anticipated to expand at a double-digit CAGR of 63.9% over the forecast period.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/artificial-intelligence-diagnostics-market